Julie Bauman, MD, MPH
Enriched profileDirector, GW Cancer Center; Professor of Medicine, George Washington University School of Medicine and Health Sciences · George Washington University School of Medicine and Health Sciences
Julie Bauman is Director, GW Cancer Center; Professor of Medicine, George Washington University School of Medicine and Health Sciences at George Washington University School of Medicine and Health Sciences. OpenAlex indexes 339 publications with 10,935 citations (h-index 49); ClinicalTrials.gov lists 17 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Julie Bauman, M.D. MPH, is Director, GW Cancer Center at George Washington University School of Medicine and Health Sciences. The public record shows 339 publications with 10,935 citations (h-index 49), centered on Head and Neck Cancer Studies, Cancer Immunotherapy and Biomarkers, HER2/EGFR in Cancer Research. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 7 companies.
- Top research focus: Head and Neck Cancer Studies
- 17 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 22 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 107.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:
- Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Sponsor: National Cancer Institute (NCI)
- Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma
Sponsor: University of Arizona
- Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers
Sponsor: National Cancer Institute (NCI)
Industry payments
Updated 16 Oct 2026
7 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- GT Medical Technologies, IncProgram year20251 payment
- Aveo Pharmaceuticals, Inc.Program year20251 payment
- Daiichi Sankyo Inc.Program year20251 payment
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
93.1%Other antiemetics87%Fosaprepitant100%Part B, office-administered≥14 patientsSerotonin-3 Receptor Antagonist6.1%Palonosetron hcl100%Part B, office-administered≥15 patientsSensory organs
6.7%Corticosteroid6.7%Dexamethasone sodium phosphate100%Part B, office-administered≥15 patientsNervous system
0.1%Phenothiazine0.1%Prochlorperazine Maleate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 16 Oct 2026
60 congress contributions (2012–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- FIERCE-HN: A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of ficlatuzumab (HGF/cMET MAb) in combination with cetuximab in participants with recurrent or metastatic (R/M) HPV negative head and neck squamous cell carcinoma (HNSCC).
ASCO Annual Meeting
ASCO2025Presenting author - Screening for social needs and providing enhanced support: Preliminary findings from a multi-center research study.
ASCO Annual Meeting
ASCO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer
Journal of Clinical Oncology
2023 - Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline
Journal of Clinical Oncology
2022
Most-cited works
by citation count (OpenAlex)- 01Head and neck squamous cell carcinomaReview4,067 citations2020
- 02
- 03
- 04Drug repurposing from an academic perspectiveArticle364 citations2011
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/julie-bauman-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
cancercenter.gwu.edu/profile/julie-bauman
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancercenter.gwu.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD/MPH
Tufts University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancercenter.gwu.edu ↗
Editorial & leadership roles
journal and society appointments- Member
National Cancer Institute Head and Neck Cancer Steering Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancercenter.gwu.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthsciences.arizona.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancercenter.arizona.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancercenter.gwu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancercenter.arizona.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →obgyn.arizona.edu ↗
- Bear Down
Beat Cancer lecture series: Head & Neck Cancer - The Emerging Epidemic
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicalimaging.medicine.arizona.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Everett Vokes, MD
University of Chicago
Maura Gillison, MD
The University of Texas MD Anderson Cancer Center
Christine Chung, MD
Moffitt Cancer Center
Tanguy Seiwert, MD
Johns Hopkins University